Post-COVID-19 syndrome and the potential benefits of exercise

A Jimeno-Almazán, JG Pallarés… - International journal of …, 2021 - mdpi.com
The coronavirus disease (COVID-19), caused by severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2) infection, is leading to unknown and unusual health conditions …

Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome

S Villapol - Translational Research, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the
greatest worldwide pandemic since the 1918 flu. The consequences of the coronavirus …

The conundrum of 'long-COVID-19: a narrative review

M Garg, M Maralakunte, S Garg, S Dhooria… - … journal of general …, 2021 - Taylor & Francis
COVID-19 is an ongoing pandemic with many challenges that are now extending to its
intriguing long-term sequel.'Long-COVID-19ʹ is a term given to the lingering or protracted …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systemic infection

A Synowiec, A Szczepański… - Clinical microbiology …, 2021 - Am Soc Microbiol
To date, seven identified coronaviruses (CoVs) have been found to infect humans; of these,
three highly pathogenic variants have emerged in the 21st century. The newest member of …

Advances and highlights in allergic rhinitis

Y Zhang, F Lan, L Zhang - Allergy, 2021 - Wiley Online Library
Allergic rhinitis (AR) is a growing public health, medical and economic problem worldwide.
The current review describes the major discoveries related to AR during the past 2 years …

Recent developments in the immunopathology of COVID‐19

H Zhang, Y Sun, Y Wang, D Yazici, D Azkur, I Ogulur… - Allergy, 2023 - Wiley Online Library
There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

M Sokolowska, T Eiwegger, M Ollert, MJ Torres… - Allergy, 2021 - Wiley Online Library
The first approved COVID‐19 vaccines include Pfizer/BioNTech BNT162B2, Moderna
mRNA‐1273 and AstraZeneca recombinant adenoviral ChAdOx1‐S. Soon after approval …

Rituximab for the treatment of multiple sclerosis: a review

CG Chisari, E Sgarlata, S Arena, S Toscano, M Luca… - Journal of …, 2022 - Springer
In the last decades, evidence suggesting the direct or indirect involvement of B cells on
multiple sclerosis (MS) pathogenesis has accumulated. The increased amount of data on …

Advances and recent developments in asthma in 2020

L Cevhertas, I Ogulur, DJ Maurer, D Burla, M Ding… - Allergy, 2020 - Wiley Online Library
In this review, we discuss recent publications on asthma and review the studies that have
reported on the different aspects of the prevalence, risk factors and prevention, mechanisms …